Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High Dose IV Esomeprazole for Prevention of Peptic Ulcer Rebleeding
NCT01757275Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Feb 2013
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of esomeprazole in Peptic ulcer hemorrhage (PUB), sponsored by AstraZeneca. Started Feb 2013; status: completed.
02
Drugs
esomeprazole
03
Conditions
Peptic ulcer hemorrhage (PUB)
Beyond the preview
Go deeper on NCT01757275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01757275.